Market Cap 592.57M
Revenue (ttm) 18.14M
Net Income (ttm) -72.85M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 649,900
Avg Vol 936,122
Day's Range N/A - N/A
Shares Out 188.72M
Stochastic %K 2%
Beta 1.98
Analysts Strong Sell
Price Target $4.50

Company Profile

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reaw...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 469 0914
Address:
701 Veterans Circle, Warminster, United States
LM_Johanssen
LM_Johanssen Jul. 4 at 4:04 PM
$ABUS God bless America and happy Independence Day to all of you, even our visitor who only posts in German 🇺🇸
1 · Reply
Alfalcon
Alfalcon Jul. 4 at 1:34 PM
$ABUS July 17 will become $ABUS independence day
1 · Reply
Blueviking
Blueviking Jul. 3 at 4:16 PM
$NWBO $ABUS $IXHL https://youtu.be/-4j2_M-4omQ?is=QLs7ZYpvmTLwPc7z
0 · Reply
Blueviking
Blueviking Jul. 3 at 1:11 PM
$ABUS Hold!!! They going to bump it to make you sell, imo hold, Much higher will follow!!!
1 · Reply
Beach27
Beach27 Jul. 3 at 1:13 AM
$ABUS Why hold ABUS, buy out $15 to $20. Tutes are the shorts, so while they wait they let retail pay them monthly payments: options, share price up and down. Tutes own 95%, market is fix. Retail must wait for the buyout. As the cash piles up, the Roche or whoever moves when the pile is big enough to fund its buyout
1 · Reply
mj6534
mj6534 Jul. 3 at 12:05 AM
$ABUS $MRNA $ROIV Criminal how dirty these two companies are. That should be us up 400-1000% insane how us shareholders were finagled and screwed over.
2 · Reply
SpaceCityKid
SpaceCityKid Jul. 2 at 9:16 PM
$ABUS Good close with a late surge. Showing +RS on an overall rough mkt day. Next stop 5.10.
0 · Reply
Heavey
Heavey Jul. 2 at 7:35 PM
$ABUS a red day?
2 · Reply
renoH4
renoH4 Jul. 2 at 7:28 PM
$ABUS $950 million upfront in July 2026 to resolve the global patent litigation over lipid nanoparticle (LNP) technology used in Moderna’s COVID vaccine. There is also a possible additional $1.3 billion payment, depending on the outcome of Moderna’s appeal involving the federal government contractor defense under 28 U.S.C. § 1498. - imo Pfizer will settle - ca. 4-5 $BILLION could be possible - in two weeks we will know it.
0 · Reply
MRenton
MRenton Jul. 2 at 6:47 PM
2 · Reply
Latest News on ABUS
Arbutus Biopharma Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Arbutus Biopharma Quarterly report: Q1 2026


Arbutus Biopharma Earnings release: Q1 2026

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Arbutus Biopharma Earnings release: Q1 2026


Arbutus Biopharma granted Fast Track designation for imdusiran

2026-04-15T11:35:22.000Z - 2 months ago

Arbutus Biopharma granted Fast Track designation for imdusiran


Arbutus Biopharma Proxy statement: Proxy filing

Apr 14, 2026, 8:00 AM EDT - 2 months ago

Arbutus Biopharma Proxy statement: Proxy filing


Arbutus Biopharma Proxy statement: Proxy filing

Apr 14, 2026, 8:00 AM EDT - 2 months ago

Arbutus Biopharma Proxy statement: Proxy filing


Arbutus Biopharma Earnings release: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 3 months ago

Arbutus Biopharma Earnings release: Q4 2025


Arbutus Biopharma Annual report: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 3 months ago

Arbutus Biopharma Annual report: Q4 2025


Why Is Moderna (MRNA) Stock Surging Today, 3/4/26?

2026-03-04T16:55:47.000Z - 4 months ago

Why Is Moderna (MRNA) Stock Surging Today, 3/4/26?

MRNA


Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)

2025-11-13T12:41:19.000Z - 8 months ago

Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)


Arbutus Biopharma Earnings release: Q3 2025

Nov 13, 2025, 7:00 AM EST - 8 months ago

Arbutus Biopharma Earnings release: Q3 2025


Arbutus Biopharma Quarterly report: Q3 2025

Nov 13, 2025, 7:00 AM EST - 8 months ago

Arbutus Biopharma Quarterly report: Q3 2025


Arbutus Biopharma Earnings release: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 11 months ago

Arbutus Biopharma Earnings release: Q2 2025


Arbutus Biopharma Quarterly report: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 11 months ago

Arbutus Biopharma Quarterly report: Q2 2025


Arbutus Biopharma Quarterly report: Q1 2025

May 14, 2025, 7:30 AM EDT - 1 year ago

Arbutus Biopharma Quarterly report: Q1 2025


Arbutus Biopharma Earnings release: Q1 2025

May 14, 2025, 7:30 AM EDT - 1 year ago

Arbutus Biopharma Earnings release: Q1 2025


Arbutus Biopharma Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Arbutus Biopharma Proxy statement: Proxy Filing


Arbutus Biopharma Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Arbutus Biopharma Proxy statement: Proxy Filing


Arbutus Biopharma Earnings release: Q4 2024

Mar 27, 2025, 7:30 AM EDT - 1 year ago

Arbutus Biopharma Earnings release: Q4 2024


Arbutus Biopharma Annual report: Q4 2024

Mar 27, 2025, 7:30 AM EDT - 1 year ago

Arbutus Biopharma Annual report: Q4 2024


Arbutus Provides 2025 Corporate and Financial Update

Jan 13, 2025, 7:30 AM EST - 1 year ago

Arbutus Provides 2025 Corporate and Financial Update


Arbutus Biopharma Transcript: Status Update

Dec 3, 2024, 11:00 AM EST - 1 year ago

Arbutus Biopharma Transcript: Status Update


Arbutus to Present at Jefferies London Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Arbutus to Present at Jefferies London Healthcare Conference


Arbutus Biopharma Earnings Call Transcript: Q3 2024

Nov 6, 2024, 8:45 AM EST - 1 year ago

Arbutus Biopharma Earnings Call Transcript: Q3 2024


Arbutus Biopharma Quarterly report: Q3 2024

Nov 6, 2024, 8:45 AM EST - 1 year ago

Arbutus Biopharma Quarterly report: Q3 2024


Arbutus Biopharma Earnings release: Q3 2024

Nov 6, 2024, 8:45 AM EST - 1 year ago

Arbutus Biopharma Earnings release: Q3 2024


Arbutus to Participate in Two Upcoming Investor Conferences

Sep 3, 2024, 7:30 AM EDT - 1 year ago

Arbutus to Participate in Two Upcoming Investor Conferences


Arbutus Biopharma Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q2 2024


Arbutus Biopharma Quarterly report: Q2 2024

Aug 1, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Quarterly report: Q2 2024


Arbutus Biopharma Earnings release: Q2 2024

Aug 1, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings release: Q2 2024


Arbutus Distributors Ltd. News Release

Jun 3, 2024, 9:50 AM EDT - 2 years ago

Arbutus Distributors Ltd. News Release


Arbutus to Present Imdusiran Data at EASL Congress 2024

May 22, 2024, 2:00 AM EDT - 2 years ago

Arbutus to Present Imdusiran Data at EASL Congress 2024


Arbutus Biopharma Earnings Call Transcript: Q1 2024

May 2, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q1 2024


Arbutus Biopharma Quarterly report: Q1 2024

May 2, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Quarterly report: Q1 2024


Arbutus Biopharma Earnings release: Q1 2024

May 2, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings release: Q1 2024


Arbutus Biopharma Proxy statement: Proxy Filing

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Arbutus Biopharma Proxy statement: Proxy Filing


Arbutus Biopharma Proxy statement: Proxy Filing

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Arbutus Biopharma Proxy statement: Proxy Filing


Arbutus Biopharma Earnings Call Transcript: Q4 2023

Feb 29, 2024, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q4 2023


Arbutus Biopharma Annual report: Q4 2023

Feb 29, 2024, 8:45 AM EST - 2 years ago

Arbutus Biopharma Annual report: Q4 2023


Arbutus Biopharma Earnings release: Q4 2023

Feb 29, 2024, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings release: Q4 2023


Arbutus Biopharma Slides: Corporate Presentation

Nov 9, 2023, 7:00 AM EST - 2 years ago

Arbutus Biopharma Slides: Corporate Presentation


Arbutus Biopharma Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q3 2023


Arbutus Biopharma Quarterly report: Q3 2023

Nov 7, 2023, 8:45 AM EST - 2 years ago

Arbutus Biopharma Quarterly report: Q3 2023


Arbutus Biopharma Earnings release: Q3 2023

Nov 7, 2023, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings release: Q3 2023


Arbutus Biopharma Earnings Call Transcript: Q2 2023

Aug 3, 2023, 8:45 AM EDT - 3 years ago

Arbutus Biopharma Earnings Call Transcript: Q2 2023


Arbutus Biopharma Quarterly report: Q2 2023

Aug 3, 2023, 8:45 AM EDT - 3 years ago

Arbutus Biopharma Quarterly report: Q2 2023


Arbutus Biopharma Earnings release: Q2 2023

Aug 3, 2023, 8:45 AM EDT - 3 years ago

Arbutus Biopharma Earnings release: Q2 2023


LM_Johanssen
LM_Johanssen Jul. 4 at 4:04 PM
$ABUS God bless America and happy Independence Day to all of you, even our visitor who only posts in German 🇺🇸
1 · Reply
Alfalcon
Alfalcon Jul. 4 at 1:34 PM
$ABUS July 17 will become $ABUS independence day
1 · Reply
Blueviking
Blueviking Jul. 3 at 4:16 PM
$NWBO $ABUS $IXHL https://youtu.be/-4j2_M-4omQ?is=QLs7ZYpvmTLwPc7z
0 · Reply
Blueviking
Blueviking Jul. 3 at 1:11 PM
$ABUS Hold!!! They going to bump it to make you sell, imo hold, Much higher will follow!!!
1 · Reply
Beach27
Beach27 Jul. 3 at 1:13 AM
$ABUS Why hold ABUS, buy out $15 to $20. Tutes are the shorts, so while they wait they let retail pay them monthly payments: options, share price up and down. Tutes own 95%, market is fix. Retail must wait for the buyout. As the cash piles up, the Roche or whoever moves when the pile is big enough to fund its buyout
1 · Reply
mj6534
mj6534 Jul. 3 at 12:05 AM
$ABUS $MRNA $ROIV Criminal how dirty these two companies are. That should be us up 400-1000% insane how us shareholders were finagled and screwed over.
2 · Reply
SpaceCityKid
SpaceCityKid Jul. 2 at 9:16 PM
$ABUS Good close with a late surge. Showing +RS on an overall rough mkt day. Next stop 5.10.
0 · Reply
Heavey
Heavey Jul. 2 at 7:35 PM
$ABUS a red day?
2 · Reply
renoH4
renoH4 Jul. 2 at 7:28 PM
$ABUS $950 million upfront in July 2026 to resolve the global patent litigation over lipid nanoparticle (LNP) technology used in Moderna’s COVID vaccine. There is also a possible additional $1.3 billion payment, depending on the outcome of Moderna’s appeal involving the federal government contractor defense under 28 U.S.C. § 1498. - imo Pfizer will settle - ca. 4-5 $BILLION could be possible - in two weeks we will know it.
0 · Reply
MRenton
MRenton Jul. 2 at 6:47 PM
2 · Reply
beckinvestllc
beckinvestllc Jul. 2 at 6:29 PM
$ABUS still waiting on that settlement...
0 · Reply
CapitalismUSA
CapitalismUSA Jul. 2 at 6:24 PM
$ABUS https://www.biopharmadive.com/news/biotech-pharma-deals-merger-acquisitions-tracker/604262/
0 · Reply
BRTO
BRTO Jul. 2 at 3:45 PM
0 · Reply
DocPharm
DocPharm Jul. 2 at 3:36 PM
$ABUS prepping to set a fresh 52 week high Near Term Target: +\- 10 % of 5.85 Mid Term: +\- 10% of 8.49
1 · Reply
DocPharm
DocPharm Jul. 2 at 3:29 PM
$ABUS it’d be quite odd but cruel satire for Moderna to buy Genevant, and then Pfizer pay them
2 · Reply
Heavey
Heavey Jul. 2 at 2:36 PM
$ABUS who here can smell a settlement announcement come the 17th?
1 · Reply
SpaceCityKid
SpaceCityKid Jul. 2 at 2:08 PM
$ABUS Shorts have to be feeling good going into a long weekend
0 · Reply
Alfalcon
Alfalcon Jul. 2 at 1:34 PM
$ABUS Happy Birthday folks. Have a great 4th of July. We may see early Christmas as well? Be safe and sane.
1 · Reply
CapitalismUSA
CapitalismUSA Jul. 2 at 1:28 PM
$ABUS POS…..
0 · Reply
DocPharm
DocPharm Jul. 2 at 11:51 AM
$ABUS no longer loses money ;)
2 · Reply
DocPharm
DocPharm Jul. 2 at 11:05 AM
Cramer also featured $ABUS 2.5 years ago and said something along the lines of that’s like the ‘eagles winning the superbowl’ Well that happened and so did the win against Moderna $MRNA Times a tickin’
0 · Reply
DocPharm
DocPharm Jul. 2 at 11:05 AM
$ABUS Cramer also featured $ABUS 2.5 years ago and said something along the lines of that’s like the ‘eagles winning the superbowl’ Well that happened and so did the win against Moderna Times a tickin’
1 · Reply